Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT07848841 · Washington University School of Medicine

Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery

What this study is about

CareOrbit is a digital perioperative patient-education and care navigation platform developed by the St. Louis-based venture Total Orbit in collaboration with Washington University's CORTEX Business Incubator.

View original scientific description

CareOrbit is a digital perioperative patient-education and care navigation platform developed by the St. Louis-based venture Total Orbit in collaboration with Washington University's CORTEX Business Incubator. For head and neck cancer (HNC) care, the platform is designed to address gaps in perioperative education by guiding patients through each stage of their surgical journey using structured modules, step-by-step instructional videos, and centralized educational resources. CareOrbit delivers physician-authored content tailored to an individual's surgical care, including overviews of surgical treatment, preoperative preparation, and expectations for postoperative recovery. Early anecdotal experiences suggest that patients appreciate the accessibility of the tool, but systematic evaluation is lacking in whether use of the tool improves understanding, satisfaction, and care outcomes. This project will address key knowledge gaps by employing a clinical trial to examine key clinical endpoints.

Interventions

OTHER

CareOrbit

CareOrbit is a digital perioperative patient-education and care navigation platform .

OTHER

Standard perioperative education

Standard of care perioperative education materials

Primary outcome measures

Change in ORTC QLQ-INFO25 Satisfaction Score

Time frame: Baseline, 30 days postoperative clinic visit, and at a 3-6 months postoperative clinic visit

The EORTC QLQ-INFO25 is a 25-item patient-reported questionnaire that assesses the amount and type of information cancer patients receive about their disease, treatment, side effects, support services, and related care. Items are rated on a 4-point scale from 1 = not at all to 4 = very much, with selected yes/no items. The total score is typically reported as 0 to 100. Higher scores indicate that more information was received and, for relevant items, greater satisfaction or perceived helpfulness of the information.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • 18 years of age or older
  • Have a new diagnosis of head and neck cancer
  • Planning or scheduled to undergo free flap surgery and/or total laryngectomy, or caregiver to eligible patients
  • Have internet access
  • English speaking

Exclusion criteria

  • Younger than 18 years of age
  • No internet access
  • Non-English speaking

Where

  • St Louis, Missouri

Collaborators

The Foundation for Barnes-Jewish Hospital

Related conditions & keywords

Head and Neck Cancer (H&N)Cancer of the Head and NeckOtolaryngologySurgeryOncology

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Sep 30, 2026 · Source of record for eligibility and locations

📊
1 of 50 participants interested
2% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

St Louis

Missouri

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Head and Neck Cancer Trials by City

Browse all head and neck cancer clinical trials in these cities — not just this study.

Looking for Head and Neck Cancer (H&N) Treatment in St Louis?

Join others in Missouri exploring innovative treatment options through clinical research

Head and Neck Cancer (H&N) Treatment Options in St Louis, Missouri

If you're searching for Head and Neck Cancer (H&N) treatment in St Louis, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in St Louis and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Head and Neck Cancer (H&N). All study-related care is provided at no cost to participants.

Local Sites
1 locations in Missouri
Now Enrolling
Up to 50 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Head and Neck Cancer (H&N)?

Potential Benefits

  • ✓Access to new treatment approaches before public availability
  • ✓Close monitoring by experienced medical professionals
  • ✓Study-related care provided at no cost
  • ✓Contribute to medical research for Head and Neck Cancer (H&N)

What to Expect

  • →Initial screening to determine eligibility
  • →Regular check-ups and monitoring visits
  • →Possible compensation for time and travel
  • →You can withdraw at any time

Frequently Asked Questions About This Head and Neck Cancer (H&N) Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT07848841. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.